FDA Inspection
Department of Defense - ArmyDepartment of Defense - Army – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns Department of Defense - Army, with an inspection on March 31, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 79ac5d95-643a-40e9-b108-3fc0d2870f66
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009238
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Army
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 21, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 16, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 30, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 12, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Army
- FDA Inspection 1246935 - 2024-07-16
- FDA Inspection 1084839 - 2019-03-21
- FDA Inspection 922990 - 2015-04-16
- FDA Inspection 842388 - 2013-07-30
- FDA Inspection 720351 - 2011-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.